WFH Cornerstone Initiative: Rwanda Marks 3 Years of Participation
The World Federation of Hemophilia (WFH) shared a proud post on X:
”The WFH recently visited our NMO in Rwanda, the Rwanda Fraternity Against Hemophilia (RFH), to meet with the new board and discuss good governance, bleeding disorders, and outreach strategies. This marks year 3 of their participation in the WFH Cornerstone Initiative.”
The World Federation of Hemophilia (WFH) recently visited the Rwanda Fraternity Against Hemophilia (RFH), its National Member Organization (NMO), as part of ongoing collaboration under the WFH Cornerstone Initiative.
Now in its third year of participation, RFH welcomed the WFH team to engage in discussions with the newly appointed board.
The visit focused on strengthening governance practices, improving national outreach, and addressing current challenges in bleeding disorder care across Rwanda.
This partnership underscores the continued commitment to building sustainable, patient-centered care systems in low-resource settings.

All the latest news in the World of Bleeding Disorders featured in Hemostasis Today.
-
Oct 9, 2026, 16:23David Boone: Distinguishing Stroke Prevention from Rhythm Control in Atrial Fibrillation
-
Oct 9, 2026, 15:27Mohamed Hegazi: Geostatistical Modelling Maps Global β-Thalassaemia Carrier Prevalence
-
Oct 9, 2026, 15:15Maha Othman: Uncovering the Consensus on TXA in TBI – Call for Collaboration on a Landmark Umbrella Review
-
Oct 9, 2026, 15:07Daniel D. Han: How Inhalation Product Exposure Impairs Cardiac and Platelet Recovery After MI
-
Oct 9, 2026, 14:58William Toole: How Ultrasound-Guided PRP Therapy Relieves Joint and Tendon Pain
-
Oct 9, 2026, 14:50Shayan Mohammadmoradi: In Corpus Christi for the 20th Midwest Platelet Conference
-
Oct 9, 2026, 14:37Tariq Tramboo: High Platelet Concentrate for Osteoarthritis Knee – Recent Meta-Analyses
-
Oct 9, 2026, 14:26Yousma Khan: Hematology Series – Beyond RBCs, WBCs and Platelets
-
Oct 9, 2026, 14:13Jesus Ardila Novoa: Why the WHO’s Historic Essential Medicines List Decision Is Just the Beginning